Reducing cross-shareholdings and reviewing the rationale for holding them
First written in FY2020. 4 of 5 entries say "Advanced", first in FY2022. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Issues with a decrease in the number of shares during the fiscal year Shares other than unlisted shares 3 2,381」
Three cross-shareholdings were sold for ¥2,381 million. All shares in Lady Drug Store were also sold. - FY2023AdvancedAnnual report
「All shares of HALOWS CO.,LTD. held by the company were sold to AEON CO.,LTD. on 6 July 2022.」
Based on the policy of reducing cross-shareholdings, Maxvalu Nishinihon sold all of its shares in HALOWS CO.,LTD. The sale price was ¥4,863 million. - FY2023-Q1AdvancedAnnual report
「To improve asset efficiency and strengthen our financial position, we sold part of the investment securities held by our subsidiary to our parent company, AEON CO.,LTD. Sale date: 6 July 2022. Gain on sale: ¥4,261 million」
In connection with the policy of reducing cross-shareholdings, 1 issue of listed shares held by a subsidiary was sold to improve asset efficiency and strengthen the financial position. - FY2022AdvancedAnnual report
「Under our basic policy of reducing cross-shareholdings whose holding purpose is considered insufficiently compelling, the Board of Directors reviews each year the significance and economic rationale of individual cross-shareholdings. The Board meeting for the current fiscal year was held on 5 July 2021. If it makes an overall determination that a holding would impair the corporate value of our company and the issuing company, we will respond promptly.」
The Board of Directors conducted an individual review of cross-shareholdings during the fiscal year. Among shares other than unlisted shares, 1 issue was sold for ¥66 million. - FY2020First statedAnnual report
「We hold shares only where maintaining and developing important collaboration and business relationships is recognized as strategically important. Under our basic policy of reducing cross-shareholdings whose holding purpose is considered insufficiently compelling, the Board of Directors verifies each year the significance and economic rationale of individual cross-shareholdings. If it makes an overall determination that a holding would impair the corporate value of our company and the issuing company, we will respond promptly.」
The company has stated for the first time a policy of holding shares only for important collaboration and business relationships, reviewing cross-shareholdings annually at the Board of Directors, and reducing or otherwise addressing holdings whose significance is insufficient.